SectorPharmaceutical
Established Date28/10/1997
Listing Date01/02/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees36
Fiscal Year Ends31/12
Security TypeCommon stock
Office address7 Golda Meir St., Weizmann Science Park , Ness Ziona, 7403650, Israel
Business
IntroductionSol-gel Technologies Ltd. Incorporated under the laws of the State of Israel on October 28, 1997. The company is an innovative dermatology company with a successful track record of two NDA approvals and a pipeline of advanced product candidates under development for orphan indications. Sol-Gel successfully developed pioneering topical drugs Twyneo and Epsolay, which were approved for the treatment of rosacea and inflammatory lesions, respectively.
